Clinical Trial Update: Cognition, Functioning and Quality of Life [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update focusing on cognition, functioning, and quality of life in schizophrenia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED